Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Diagnosed With Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00037180
What this trial is testing

For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy

Who this might be right for
Neoplasm MetastasisColorectal Neoplasms
Pfizer 212
Testing effectiveness (Phase 2)Study completedNCT02805179
What this trial is testing

High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma

Who this might be right for
Glioma
University of Michigan Rogel Cancer Center 26
Post-approval studies (Phase 4)Study completedNCT00686725
What this trial is testing

Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)

Who this might be right for
Glioblastoma
Merck Sharp & Dohme LLC 99
Not applicableStudy completedNCT00316823
What this trial is testing

Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules

Who this might be right for
Head and Neck Cancer
University of California, San Francisco 400
Large-scale testing (Phase 3)Study completedNCT00379340
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

Who this might be right for
Stage III Kidney Wilms TumorStage IV Kidney Wilms Tumor
Children's Oncology Group 395
Not applicableNot Yet RecruitingNCT07366450
What this trial is testing

High-Dose vs Standard Ergocalciferol for Vitamin D Normalization in Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Vitamin D 25-Hydroxylase DeficiencyLymphoma Non-Hodgkin
Phramongkutklao College of Medicine and Hospital 52
Large-scale testing (Phase 3)Study completedNCT00004218
What this trial is testing

Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Leukemia Research Fund
Not applicableUnknownNCT05153603
What this trial is testing

Outcomes of First-line Olaparib Mono-maintenance therapy-a Multicenter, Retrospective Study Using Data From Real-world Clinical Setting

Who this might be right for
Ovarian Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 50
Early research (Phase 1)Study completedNCT01693991
What this trial is testing

Randomized Controlled Trial of the Meaning-Making Intervention (MMi)

Who this might be right for
Advanced Cancer
Jewish General Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT07153796
What this trial is testing

A Phase 1b/2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT01341262
What this trial is testing

THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 378
Testing effectiveness (Phase 2)Looking for participantsNCT06056362
What this trial is testing

Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Peking Union Medical College Hospital 80
Not applicableStudy completedNCT03471546
What this trial is testing

Early Palliative Care Intervention in Malignant Glioma

Who this might be right for
Malignant Glioma
Duke University 12
Testing effectiveness (Phase 2)Study completedNCT01977677
What this trial is testing

Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma

Who this might be right for
Adult EpendymoblastomaAdult Giant Cell GlioblastomaAdult Glioblastoma+6 more
Lawrence Recht 30
Testing effectiveness (Phase 2)Study completedNCT01238211
What this trial is testing

Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11+5 more
National Cancer Institute (NCI) 61
Testing effectiveness (Phase 2)WithdrawnNCT04065087
What this trial is testing

Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Newly Diagnosed Glioblastoma
Genexine, Inc.
Large-scale testing (Phase 3)Ended earlyNCT00104936
What this trial is testing

Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 9
Not applicableStudy completedNCT02663232
What this trial is testing

Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma

Who this might be right for
Metastatic Cancers
Hoffmann-La Roche 264
Large-scale testing (Phase 3)Active Not RecruitingNCT06746116
What this trial is testing

Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in Spain

Who this might be right for
Advanced or Recurrent Endometrial Cancer
AstraZeneca 45
Testing effectiveness (Phase 2)Study completedNCT00739388
What this trial is testing

Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive Chemotherapy

Who this might be right for
Leukemia
Swiss Cancer Institute 47
Next Page